Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Gonadotropin-releasing hormone Stories

Female Goats Go GaGa Over Males’ Hairy Head Stench
2014-02-28 13:56:36

[ Watch the Video: What's That Smell? Lady Goats Love It At Least ] Lawrence LeBlond for redOrbit.com - Your Universe Online Most goats have a certain unpleasant odor that does a number on the olfactory system of any passing humans. But a new study published in the journal Current Biology has identified a chemical released by the male goat that causes the female of the species to get excited. This seemingly unpleasant stench may not get our juices flowing, but to female goats, it is...

2014-02-03 08:27:19

QUÉBEC CITY, Feb. 3, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that presentations on two of its oncology compounds, zoptarelin doxorubicin (AEZS-108) and disorazol Z, will be made during the 11(th) International Symposium on GnRH, in Salzburg, Austria, February 9 -11, 2014. The session will be held on Tuesday, February 11, 2014, in Hall A of the Wyndham Hotel in Salzburg. Presentations are scheduled as follows:...

2014-01-13 12:28:06

LAUSANNE, Switzerland, January 13, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, announces that it has completed the recruitment of patients for its Phase III clinical study in Central Precocious Puberty (CPP) with triptorelin 22.5 mg. Debiopharm is investigating the efficacy and safety of...

Researchers Discover Brain Actually Produces Estrogen Too
2013-12-05 10:53:07

April Flowers for redOrbit.com - Your Universe Online The brain can produce and release estrogen, according to a new study from the University of Wisconsin-Madison. This discovery could lead to a better understanding of hormonal changes observed from before birth throughout the entire aging process. The study findings, published in the Journal of Neuroscience, reveal that the hypothalamus can directly control reproductive function in rhesus macaques. The researchers suggest that the...

2013-08-29 12:25:38

SAN DIEGO, Aug. 29, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that the second Phase III pivotal trial to evaluate elagolix for the treatment of endometriosis has been initiated by AbbVie. This second Phase III trial is similar in design to the initial Phase III trial which is scheduled to provide top-line data in the third quarter of 2014 and complete in 2015. "We are pleased that the second Phase III study in endometriosis has been launched,"...

2013-07-17 10:55:52

During the last decade, our understanding of this hypothalamus-pituitary-gonadal axis has quickly expanded. Two novel hypothalamic Arg-Phe-amide- related peptides, kisspeptin and gonadotropin-inhibitory hormone, may be important regulators of the reproductive axis. Kisspeptins are currently recognized as the most potent activators of the hypothalamus-pituitary-gonadal axis. Kisspeptin and its receptor, G protein-coupled receptor 54 (GPR54), are expressed on gonadotropin-releasing hormone...

2013-05-01 16:29:44

NEW YORK, May 1, 2013 /PRNewswire-USNewswire/ -- While the search continues for the Fountain of Youth, researchers may have found the body's "fountain of aging": the brain region known as the hypothalamus. For the first time, scientists at Albert Einstein College of Medicine of Yeshiva University report that the hypothalamus of mice controls aging throughout the body. Their discovery of a specific age-related signaling pathway opens up new strategies for combating diseases of old age and...

2013-04-03 08:27:32

QUÉBEC CITY, April 3, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that Babette Aicher, PhD, Director of Preclinical Development, will be making a poster presentation on updated proof-of-concept results for Disorazol Z cytotoxic conjugates, such as AEZS-125 and AEZS-138, in human ovarian and endometrial cancer xenograft models, at the upcoming American Association for Cancer Research ("AACR") annual meeting,...

2013-01-18 08:23:29

MIAMI, Jan. 18, 2013 /PRNewswire/ -- Biscayne Pharmaceuticals, Inc. today announced that it has closed a $1.5 million financing. The new company is developing novel growth hormone-releasing hormone (GHRH) drugs based on recent discoveries by the company's scientific advisor, Dr. Andrew V. Schally, a world-renowned drug researcher and Nobel laureate who pioneered the field of hypothalamic peptide drugs. Biscayne also announced that it has exclusively licensed intellectual property from the...

2012-11-08 08:34:10

QUÉBEC CITY, CANADA, Nov. 8, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today presented encouraging preclinical results for disorazol Z cytotoxic conjugates, such as AEZS-125, in ovarian cancer. Results showed the compound's high potential for the treatment of luteinizing hormone-releasing hormone (LHRH) receptor positive tumors. Data were presented by the Company's Director of Preclinical Development, Babette Aicher, PhD,...